Compliance

PRODUCTS

  • The most widely trusted solution for clinical trial disclosure management

    Managing clinical trial disclosures can be tedious and error-prone, opening the door to noncompliance. TrialScope Disclose provides a better way.

    Our centralized platform automates data entry and reporting for Clinicaltrials.gov, CTIS, and more. This reduces manual effort so you can focus on bringing new treatments to patients, not paperwork.

  • Purpose-built with users at the center to make it easier and more efficient to get quality patient outcomes data for submissions and approvals.

    Collecting quality data on patient outcomes is often one of the most important parts of a clinical trial. It is also challenging, and many eCOA solutions make it feel even more difficult with complicated processes, lack of questionnaire reusability, slow set up, and difficult to use tech.

  • Whenever possible, Mueller tailors product certification to match specific job requirements, including part numbers, job identification, and funding agency requirements. We have developed this process working closely with the Environmental Protection Agency (EPA) who was very early in clarifying definitions and requirements for Iron & Steel Products, Construction Materials, and other Manufactured Products.

  • Qorvo's QPA2811 is a high-performance, packaged X-band power amplifier designed for demanding applications such as military radar systems.

  • A Transfection Solution for Gram-Scale Protein Production

    The ExPERT VLx system delivers unmatched transfection scalability with MaxCyte's Flow Electroporation® technology for industry-leading reproducibility, flexibility and ease of use.

    • Reduce time, cost and risk
    • Transfect up to 200 billion cells, in a single-use system, in less than 30 minutes
    • Obtain grams of proteins in weeks, not months
    • Achieve reproducible results, superior transfection efficiency, cell viability and protein expression
    • Scale seamlessly to expedite your transition from discovery to Phase 1
    • Proprietary Flow Electroporation® Technology

WHITE PAPERS AND CASE STUDIES

NEWS